RU2670882C9 - Непатогенный штамм f18 е. coli и его применение - Google Patents

Непатогенный штамм f18 е. coli и его применение Download PDF

Info

Publication number
RU2670882C9
RU2670882C9 RU2015105738A RU2015105738A RU2670882C9 RU 2670882 C9 RU2670882 C9 RU 2670882C9 RU 2015105738 A RU2015105738 A RU 2015105738A RU 2015105738 A RU2015105738 A RU 2015105738A RU 2670882 C9 RU2670882 C9 RU 2670882C9
Authority
RU
Russia
Prior art keywords
strain
coli
pathogenic
animals
live
Prior art date
Application number
RU2015105738A
Other languages
English (en)
Russian (ru)
Other versions
RU2015105738A (ru
RU2670882C2 (ru
Inventor
Джон Моррис ФЭЙРБРАЗЕР
Эрик НАДО
Кларисс ДЕЗОТЕЛЬ
Original Assignee
Превтек Майкробиа Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Превтек Майкробиа Инк. filed Critical Превтек Майкробиа Инк.
Publication of RU2015105738A publication Critical patent/RU2015105738A/ru
Publication of RU2670882C2 publication Critical patent/RU2670882C2/ru
Application granted granted Critical
Publication of RU2670882C9 publication Critical patent/RU2670882C9/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
RU2015105738A 2012-07-20 2013-07-18 Непатогенный штамм f18 е. coli и его применение RU2670882C9 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261674179P 2012-07-20 2012-07-20
US61/674,179 2012-07-20
PCT/CA2013/000660 WO2014012172A1 (en) 2012-07-20 2013-07-18 Non-pathogenic f18 e. coli strain and use thereof

Publications (3)

Publication Number Publication Date
RU2015105738A RU2015105738A (ru) 2016-09-10
RU2670882C2 RU2670882C2 (ru) 2018-10-25
RU2670882C9 true RU2670882C9 (ru) 2018-12-11

Family

ID=49948133

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015105738A RU2670882C9 (ru) 2012-07-20 2013-07-18 Непатогенный штамм f18 е. coli и его применение

Country Status (17)

Country Link
US (3) US9453195B2 (enExample)
EP (1) EP2875121B1 (enExample)
JP (1) JP6278960B2 (enExample)
KR (1) KR102171028B1 (enExample)
CN (1) CN104736695B (enExample)
BR (1) BR112015001175B1 (enExample)
CA (1) CA2879155C (enExample)
DK (1) DK2875121T3 (enExample)
ES (1) ES2663019T3 (enExample)
HU (1) HUE036545T2 (enExample)
MX (1) MX363057B (enExample)
PH (1) PH12015500091A1 (enExample)
PL (1) PL2875121T3 (enExample)
PT (1) PT2875121T (enExample)
RS (1) RS57056B1 (enExample)
RU (1) RU2670882C9 (enExample)
WO (1) WO2014012172A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102171028B1 (ko) 2012-07-20 2020-10-28 프레브테크 마이크로비아 인코포레이티드 비 병원성 f18 대장균 균주 및 이의 용도
MX384826B (es) * 2015-02-11 2025-03-14 Evah Nutrition Inc Matriz seca mejorada para incrustar escherichia coli viable, metodo para hacer la misma y uso de la misma.
KR101715625B1 (ko) * 2015-06-02 2017-03-13 대한민국(농림축산식품부 농림축산검역본부장) 부종병 독소를 생산하는 대장균, 이를 이용한 부종병 독소의 생산방법 및 이를 포함하는 돼지 부종병 예방용 백신 조성물
CA3027896C (en) * 2016-06-14 2021-07-13 Prevtec Microbia Inc. Animal feed pellets including a feed additive, method of making and of using same
US20200113950A1 (en) * 2017-06-30 2020-04-16 The Rockefeller University Human microbiota derived N-acyl amides for the treatment of human disease
CN107523529B (zh) * 2017-10-20 2021-03-12 林州中农颖泰生物肽有限公司 一种利用大肠杆菌生产肠杆菌肽的工艺及其应用
CN109628361B (zh) * 2018-11-27 2022-08-19 扬州大学 整合双拷贝功能性f4菌毛操纵子基因猪源益生菌ep1克隆株、构建方法及应用
CN109504643B (zh) * 2018-11-27 2022-06-10 扬州大学 整合四拷贝功能性f18菌毛操纵子基因的益生菌克隆株、构建方法及应用
CN114752531B (zh) * 2022-04-29 2023-05-26 扬州大学 一株同时表达f4和f18菌毛的猪源大肠杆菌无毒分离株及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
WO2000058476A1 (en) * 1999-03-31 2000-10-05 Mta Állatorvos-Tudományi K.I. A strain suitable for producing a live, orally applicable escherichia coli vaccine for the prevention of postweaning diarrhoea in pigs and the procedure suitable for producing that strain
US20070218035A1 (en) * 2004-02-03 2007-09-20 Eric Nadeau Use of Live Bacteria for Growth Promotion in Animals
WO2010005868A2 (en) * 2008-07-08 2010-01-14 South Dakota State University A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6355859B1 (en) 1997-05-20 2002-03-12 Biotechnology Research And Development Corporation Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
IL141142A0 (en) * 1998-07-30 2002-02-10 Wisconsin Alumni Res Found Gastrointestinal bacterial antibody factories
US6304216B1 (en) 1999-03-30 2001-10-16 Conexant Systems, Inc. Signal detector employing correlation analysis of non-uniform and disjoint sample segments
IL130303A0 (en) * 1999-06-03 2000-06-01 M G Novobiotech Ltd A bacterial strain processed plant extracts and probiotic compositions for human and veterinary use
CA2430292A1 (en) 2000-11-30 2002-06-06 The Bio Balance Corp. Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof
AU2003287028B2 (en) 2002-10-04 2008-09-04 E.I. Du Pont De Nemours And Company Process for the biological production of 1,3-propanediol with high yield
CA2566617C (en) * 2004-05-14 2013-12-31 Agtech Products, Inc. Method and composition for reducing e.coli disease and enhancing performance using bacillus
KR102171028B1 (ko) 2012-07-20 2020-10-28 프레브테크 마이크로비아 인코포레이티드 비 병원성 f18 대장균 균주 및 이의 용도

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2125455C1 (ru) * 1996-09-25 1999-01-27 Саратовская научно-исследовательская ветеринарная станция Способ профилактики диареи молодняка сельскохозяйственных животных
WO2000058476A1 (en) * 1999-03-31 2000-10-05 Mta Állatorvos-Tudományi K.I. A strain suitable for producing a live, orally applicable escherichia coli vaccine for the prevention of postweaning diarrhoea in pigs and the procedure suitable for producing that strain
US20070218035A1 (en) * 2004-02-03 2007-09-20 Eric Nadeau Use of Live Bacteria for Growth Promotion in Animals
WO2010005868A2 (en) * 2008-07-08 2010-01-14 South Dakota State University A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
FAIRBROTHER J. M. ET AL. Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies// Animal Health Research Reviews, 2005, 6(1); 17-39. BERTSCHINGER H.U. ET AL. Active oral immunization of suckling piglets to prevent colonization after weaning by enterotoxigenic Escherichia coli with fimbriae F18 // Veterinary Microbiology 71 (2000) 255-267. *

Also Published As

Publication number Publication date
EP2875121A4 (en) 2016-01-13
MX2015000905A (es) 2015-09-28
JP2015525566A (ja) 2015-09-07
US20180008651A1 (en) 2018-01-11
JP6278960B2 (ja) 2018-02-14
HUE036545T2 (hu) 2018-07-30
DK2875121T3 (en) 2018-04-16
US9775867B2 (en) 2017-10-03
US20150152377A1 (en) 2015-06-04
KR20150036698A (ko) 2015-04-07
CA2879155C (en) 2024-04-30
CA2879155A1 (en) 2014-01-23
KR102171028B1 (ko) 2020-10-28
EP2875121B1 (en) 2018-01-03
US20160361369A1 (en) 2016-12-15
PH12015500091B1 (en) 2015-03-02
RU2015105738A (ru) 2016-09-10
PH12015500091A1 (en) 2015-03-02
CN104736695B (zh) 2017-05-24
ES2663019T3 (es) 2018-04-10
PL2875121T3 (pl) 2018-06-29
EP2875121A1 (en) 2015-05-27
RU2670882C2 (ru) 2018-10-25
BR112015001175A2 (pt) 2017-06-27
CN104736695A (zh) 2015-06-24
WO2014012172A1 (en) 2014-01-23
BR112015001175B1 (pt) 2022-03-03
HK1209780A1 (en) 2016-04-08
US9453195B2 (en) 2016-09-27
US10258654B2 (en) 2019-04-16
MX363057B (es) 2019-03-06
PT2875121T (pt) 2018-03-14
RS57056B1 (sr) 2018-05-31

Similar Documents

Publication Publication Date Title
RU2670882C2 (ru) Непатогенный штамм f18 е. coli и его применение
Kyriakis et al. The effect of probiotic LSP 122 on the control of post-weaning diarrhoea syndrome of piglets
US8722058B2 (en) Bacillus strains and methods for reducing E. coli disease and enhancing performance
US9011836B2 (en) Methods of treating pigs with Bacillus strains
US9861665B2 (en) Use of UVE bacteria for growth promotion in animals
KR20030082549A (ko) 박테리아 균주, 처리된 식물 추출물, 이를 함유하는조성물, 이의 제조방법 및 치료적 용도 및 산업적 용도
HK1209780B (en) Non-pathogenic f18 e. coli strain and use thereof
Nhi et al. SWINE COLIBACILLOSIS IN PIG
Thornton Siderophore receptor and porin protein-based vaccine technology: an intervention strategy for pre-harvest control of Escherichia coli O157 in cattle
Kantas et al. A feed additive containing Bacillus toyonensis in weaning piglets

Legal Events

Date Code Title Description
TH4A Reissue of patent specification
PD4A Correction of name of patent owner
PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20210315